The Automated Screening Working Groups is a group of software engineers and biologists passionate about improving scientific manuscripts on a large scale. Our members have created tools that check for common problems in scientific manuscripts, including information needed to improve transparency and reproducibility. We have combined our tools into a single pipeline, called ScreenIT. We're currently using our tools to screen COVID preprints.

About Followers

Latest preprint reviews

  1. Testing Frequency Matters: An Evaluation of the Diagnostic Performance of a Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Rapid Antigen Test in US Correctional Facilities

    1. Margaret L Lind
    2. Olivia L Schultes
    3. Alexander J Robertson
    4. Amy J Houde
    5. Derek A T Cummings
    6. Albert I Ko
    7. Byron S Kennedy
    8. Robert P Richeson

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. SARS-CoV-2 Omicron Variant Infection of Individuals with High Titer Neutralizing Antibodies Post-3 rd mRNA Vaccine Dose

    1. Alexa J. Roeder
    2. Megan A. Koehler
    3. Sergei Svarovsky
    4. Paniz Jasbi
    5. Alim Seit-Nebi
    6. Maria J. Gonzalez-Moa
    7. John Vanderhoof
    8. Davis McKechnie
    9. Baylee A. Edwards
    10. Douglas F. Lake

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Open label phase I/II clinical trial and predicted efficacy of SARS-CoV-2 RBD protein vaccines SOBERANA 02 and SOBERANA Plus in children

    1. Rinaldo Puga-Gómez
    2. Yariset Ricardo-Delgado
    3. Chaumey Rojas-Iriarte
    4. Leyanis Céspedes-Henriquez
    5. Misleidys Piedra-Bello
    6. Dania Vega-Mendoza
    7. Noelvia Pestana Pérez
    8. Beatriz Paredes-Moreno
    9. Meiby Rodríguez-González
    10. Carmen Valenzuela-Silva
    11. Belinda Sánchez-Ramírez
    12. Laura Rodríguez-Noda
    13. Rocmira Pérez-Nicado
    14. Raul González-Mugica
    15. Tays Hernández-García
    16. Talía Fundora-Barrios
    17. Martha Dubet Echevarría
    18. Juliet María Enriquez-Puertas
    19. Yenicet Infante Hernández
    20. Ariel Palenzuela-Díaz
    21. Evelyn Gato-Orozco
    22. Yanet Chappi-Estévez
    23. Julio Cesar Francisco-Pérez
    24. Miladi Suarez Martinez
    25. Ismavy C. Castillo-Quintana
    26. Sonsire Fernandez-Castillo
    27. Yanet Climent-Ruiz
    28. Darielys Santana-Mederos
    29. Yanelda García-Vega
    30. María Eugenia Toledo-Romani
    31. Delaram Doroud
    32. Alireza Biglari
    33. Yury Valdés-Balbín
    34. Dagmar García-Rivera
    35. Vicente Vérez-Bencomo
    36. SOBERANA Research Group

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. SARS-CoV-2 Seroprevalence among Healthcare Workers after the First and Second Pandemic Waves

    1. Nathalie de Visscher
    2. Xavier Holemans
    3. Aline Gillain
    4. Anne Kornreich
    5. Raphael Lagasse
    6. Philippe Piette
    7. Manfredi Ventura
    8. Frédéric Thys

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Development of a COVID-19 risk assessment model for participants at outdoor music festivals: evaluation of the validity and control measure effectiveness based on two actual events in Japan and Spain

    1. Michio Murakami
    2. Tsukasa Fujita
    3. Pinqi Li
    4. Seiya Imoto
    5. Tetsuo Yasutaka

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Assessment of aerosol persistence in ICUs via low-cost sensor network and zonal models

    1. K. Glenn
    2. J. He
    3. R. Rochlin
    4. S. Teng
    5. J. G. Hecker
    6. I. Novosselov

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Different forms of superspreading lead to different outcomes: Heterogeneity in infectiousness and contact behavior relevant for the case of SARS-CoV-2

    1. Elise J. Kuylen
    2. Andrea Torneri
    3. Lander Willem
    4. Pieter J. K. Libin
    5. Steven Abrams
    6. Pietro Coletti
    7. Nicolas Franco
    8. Frederik Verelst
    9. Philippe Beutels
    10. Jori Liesenborgs
    11. Niel Hens

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Immunogenicity and safety of booster dose of S-268019-b or BNT162b2 in Japanese participants: An interim report of phase 2/3, randomized, observer-blinded, noninferiority study

    1. Masaharu Shinkai
    2. Takuhiro Sonoyama
    3. Akari Kamitani
    4. Risa Yokokawa Shibata
    5. Naomi M. Seki
    6. Shinya Omoto
    7. Masahiro Shinoda
    8. Takashi Sato
    9. Naoki Ishii
    10. Kenji Igarashi
    11. Mari Ariyasu

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Spike mutations of the SARS-CoV-2 Omicron: more likely to occur in the epitopes

    1. Hu Li
    2. Zhiwei Chen
    3. Xiaoqing Liu
    4. Peng Hu

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac, ChAdox1 nCov-19 and BNT162b2 plus BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults

    1. Suvimol Niyomnaitham
    2. Zheng Quan Toh
    3. Patimaporn Wongprompitak
    4. Laddawan Jansarikit
    5. Kanjana Srisutthisamphan
    6. Sompong Sapsutthipas
    7. Yuparat Jantraphakorn
    8. Natthakarn Mingngamsup
    9. Paul V Licciardi
    10. Kulkanya Chokephaibulkit

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Newer Page 586 of 2361 Older